Split Personality: How a Divided Congress May Hit Banks, Tech & Pharma

557 views · Published 6 November 2018 · 4:05 · Indexed 26 October 2026

Channel: Bloomberg Television · 2018 · News & Politics

Watch on YouTube

Nov.05 -- With a divided U.S. Congress, analysts think bank and pharmaceutical stocks could come out relatively unharmed, or even supported, if Democrats cause gridlock with Donald Trump's agenda. But the pain could continue for tech and industrials as privacy concerns and trade wars may not go away soon. Ramy Inocencio explains on "Bloomberg Daybreak: Asia."

More from this channel